To develop innovative and safe multivalent anti-opioid vaccines that protect against heroin and fentanyl.
Active Definitive Contract Awarded Last action
- Contract number
- 75N93020C00039
- Awardee
-
University Of Montana UEI DAY7Z8ZD48Q3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,915,968
Award facts
- Opportunity
-
- Development of Vaccines for the Treatment of Opioid Use Disorder Pre-Solicitation · BAADAIT75N93019R00009 · Posted Mar 5, 2019
- Development of Vaccines for the Treatment of Opioid Use Disorder Award Notice · Posted Sep 3, 2020
- Contract value 78% obligated
-
- $25,915,968.00 Current, with exercised options
- $33,419,572.00 Potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Missoula, MT 59812, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,155,829 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $7,352,416 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $10,407,723 |
Show all 11
About this award
The National Institute of Allergy and Infectious Diseases awarded a $33.4 million definitive contract to the University of Montana for development of innovative and safe multivalent anti-opioid vaccines that protect against heroin and fentanyl, with an ultimate completion date of September 29, 2027. The award was made on September 30, 2020, under a cost-reimbursable, no-fee structure with no set-aside designation.
Place of performance is Missoula, Montana. The originating pre-solicitation, posted in March 2019, solicited proposals for multivalent opioid vaccines through fiscal year 2024, targeting high-affinity antibodies to prevent opioids from crossing the blood-brain barrier. The solicitation anticipated a 12-month base period with four option years and up to $30 million in total funding across multiple awards. NAICS code 325414 and PSC code R421 apply.
The University of Montana is performing the work with subcontractors including the Regents of the University of Minnesota (awarded May 12, 2026), Research Foundation For Mental Hygiene, Inc. operating through the New York State Psychiatric Institute (May 12, 2026), Inimmune Corp for synthetic and formulation process development and manufacturing oversight (May 11, 2025), the University of Washington for animal studies and vaccine efficacy testing (May 7, 2025), and Hennepin Healthcare Research Institute for vaccine efficacy studies in rats (April 18, 2025).
Service Contract Inventory reporting shows the prime's federal labor footprint at 6.3 FTEs and 13,124 contractor hours in FY2025, with government-paid rates at $262.80 per hour. In FY2025, 90 percent of contractor hours were subcontracted out across five named subcontractors. Prior-year SCI invoicing totaled $1.4 million in FY2021, $1.5 million in FY2022, and $218 thousand in FY2024.
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| Research Foundation For Mental Hygiene, Inc. | $4,929,980 | |
| Regents Of The University Of Minnesota | $2,358,449 | |
| Inimmune Corp | $9,186,089 | |
| University Of Washington | $2,585,143 | |
| Hennepin Healthcare Research Institute | $1,046,866 |
Quick answers
Who was awarded contract 75N93020C00039?
75N93020C00039 was awarded to University Of Montana by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2020.
How much is contract 75N93020C00039 worth?
The government has obligated $25,915,968 on 75N93020C00039. Its potential value, with all options, is $33,419,572.
Was contract 75N93020C00039 competed?
The extent of competition for 75N93020C00039 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award